Cargando…
The metabolism of human soluble amyloid precursor protein isoforms is quantifiable by a stable isotope labeling-tandem mass spectrometry method
Evidence suggests that β-secretase (BACE1), which cleaves Amyloid Precursor Protein (APP) to form sAPPβ and amyloid-β, is elevated in Alzheimer's disease (AD) brains and biofluids and, thus, BACE1 is a therapeutic target for this devastating disease. The direct product of BACE1 cleavage of APP,...
Autores principales: | Dobrowolska Zakaria, Justyna A., Bateman, Randall J., Lysakowska, Monika, Khatri, Ammaarah, Jean-Gilles, Dinorah, Kennedy, Matthew E., Vassar, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440206/ https://www.ncbi.nlm.nih.gov/pubmed/36056033 http://dx.doi.org/10.1038/s41598-022-18869-3 |
Ejemplares similares
-
Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014) -
Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis
por: Sadleir, Katherine R., et al.
Publicado: (2022) -
A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018) -
A promising new γ-secretase modulator for Alzheimer’s disease
por: Dobrowolska Zakaria, Justyna A., et al.
Publicado: (2021) -
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
por: Povala, Guilherme, et al.
Publicado: (2021)